A 21-year-old woman who went to a Connecticut hospital for a serious ankle fracture died days later after allegedly receiving excessive doses of opioid pain medication, according to a wrongful-death lawsuit filed by her father.
Dale Alice Martin was admitted to Waterbury Hospital on April 9, 2025, after breaking her ankle while working on a farm during a gap year from college. Her family says she was expected to undergo surgery the following morning. Instead, the lawsuit alleges, a night of pain treatment and inadequate monitoring ended in a medical emergency from which she could not recover.
The complaint claims that hospital staff administered such high doses of pain medication that Martin’s breathing slowed dangerously. Her family alleges that she was left without adequate supervision as her condition deteriorated and could not call for help.
Martin was resuscitated after being found unresponsive, but the resulting brain injury was too severe for recovery. She was declared brain-dead on April 13, four days after her hospital admission.
The allegations have raised questions about medication safety, patient monitoring and the responsibilities of healthcare providers caring for patients receiving powerful painkillers.
A farm accident led to an unexpected hospital stay
Martin was working on a New England farm when she tripped and fractured her ankle. According to the lawsuit, the injury was complex enough that doctors determined she would need surgery.
The young woman was reportedly in considerable pain after arriving at the hospital. Court documents describe her repeatedly crying and rating her pain at 10 out of 10. The complaint says morphine provided only brief relief, lasting approximately five minutes.
Despite her discomfort, Martin appeared well enough to reassure her family during a FaceTime call that evening. According to the complaint, she smiled while speaking with them.
For her loved ones, that moment would become a painful reminder of how unexpectedly the situation changed.
As the evening progressed, hospital staff administered opioid medications, including morphine and oxycodone, according to the lawsuit. The family alleges that the amount and combination of medication impaired Martin’s ability to breathe normally.
The complaint describes her breathing slowing as oxygen levels fell, leaving her increasingly vulnerable while sedated.
Her family argues that appropriate monitoring could have helped staff recognize the deterioration and intervene before the situation became irreversible.
The lawsuit alleges that warning signs went unnoticed
According to the complaint, Martin remained in her hospital bed as the effects of the medication worsened. Her family alleges that staff failed to check on her adequately and that she was unable to call for assistance while struggling to breathe.
A nurse eventually checked on her the following morning and found her unresponsive, the lawsuit states. Martin had stopped breathing, and her heart had stopped.
Hospital personnel were able to resuscitate her, but the lack of oxygen had caused catastrophic brain damage. She was subsequently diagnosed with anoxic encephalopathy, a condition involving brain injury caused by insufficient oxygen reaching brain tissue.
Severe oxygen deprivation can damage brain cells within minutes. The extent of the injury depends on factors including how long the brain is deprived of oxygen and how quickly circulation and breathing are restored.
In Martin’s case, the complaint says the injury was so severe that there was no realistic possibility of recovery. She was declared brain-dead four days after she was admitted.
Her father subsequently filed the lawsuit, naming Waterbury Hospital and a doctor among the defendants.
The complaint alleges failures involving staff supervision, staffing levels, medication management and monitoring. It contends that these failures contributed to Martin’s death and seeks financial damages.
These are allegations made in a civil lawsuit, rather than findings of liability established by a court.
Why opioid monitoring matters in hospitals
Opioids are powerful medications commonly used to treat moderate to severe pain, including pain associated with major fractures and surgery. When appropriately prescribed and monitored, they can be an important part of medical treatment.
However, these medications can also suppress the body’s drive to breathe. Excessive sedation and respiratory depression may cause breathing to become slow or shallow, reducing the amount of oxygen reaching vital organs, including the brain.
The risk is particularly concerning when patients receive repeated doses or take opioids alongside other medicines that depress the central nervous system.
The U.S. Food and Drug Administration warns that opioid pain medicines can cause life-threatening respiratory depression. Its safety guidance emphasizes appropriate dosing, reassessment of patients and education about the warning signs of breathing problems.
In a hospital setting, monitoring may include repeated assessments of alertness, breathing rate and oxygen saturation. Depending on the patient’s condition and medications, clinicians may use additional monitoring to identify respiratory deterioration.
Recognizing changes early is important because a heavily sedated patient may not be able to communicate distress or seek help independently.
Martin’s lawsuit raises questions about whether her medication treatment and level of observation were appropriate under the circumstances. Those questions will need to be evaluated through the legal process and the relevant medical evidence.
Family points to alleged staffing and supervision failures
Martin’s father argues that his daughter’s death was not simply the result of an unpredictable medical complication. The lawsuit alleges that preventable failures in the hospital’s care allowed the situation to escalate.
Among the issues raised are whether staff members were adequately supervised, whether staffing levels were sufficient and whether medical personnel properly assessed the effects of the medications being administered.
The complaint also questions whether alternative approaches to pain management were adequately considered.
Managing severe pain can require difficult clinical decisions, particularly when a patient is waiting for surgery. Doctors must balance effective pain relief with the potential side effects of medication, while nurses and other healthcare professionals must monitor patients for signs of deterioration.
The lawsuit contends that those responsibilities were not fulfilled in Martin’s case.
The claims have not, by themselves, established that any individual or organization was legally responsible for her death. A court proceeding may examine the medical records, medication administration, monitoring procedures and decisions made by the people involved in her care.
Hospital ownership changed after Martin’s death
Waterbury Hospital was owned by Prospect Medical Holdings when Martin died in April 2025. The company subsequently faced bankruptcy proceedings as its healthcare operations underwent significant financial and organizational changes.
In 2026, UConn Health acquired Waterbury Hospital through a $13 million transaction intended to preserve healthcare services for the surrounding community.
The change in ownership occurred after Martin’s death. UConn Health has stated that patient quality, safety and well-being are its top priorities and directed questions about the lawsuit to Prospect Medical Holdings.
Prospect reportedly did not respond to a request for comment on the allegations.
The ownership transition adds another dimension to the case, but it does not itself determine responsibility for the treatment Martin received in 2025. The allegations concern care delivered under the hospital’s ownership at that time.
A case with wider implications for patient safety
Martin’s death highlights the importance of safe medication practices and careful observation when patients receive opioids in healthcare settings.
Pain management is an essential part of treatment, particularly for patients with severe injuries. But administering medication is only one part of that responsibility. Healthcare teams must also assess how patients respond, identify potentially dangerous side effects and act promptly when breathing or consciousness changes.
The case also illustrates why staffing, communication and clear procedures matter. Even when hospitals have medication policies in place, those safeguards must be followed consistently at the bedside.
For Martin’s family, the lawsuit seeks accountability for what they believe were preventable failures during a hospital visit that began with a broken ankle.
Their central allegation is that the young woman entered the hospital for treatment of an injury and died after the care intended to help her became, in their account, a source of fatal harm.
The legal proceedings will determine how those claims are assessed. For now, the case raises a sobering question about hospital safety: whether patients receiving powerful pain medication are being monitored closely enough to ensure that complications are recognized before it is too late.
